Attention-gated U-Net model for semantic segmentation of brain tumors and feature extraction for survival prognosis
arXiv:2602.15067v1 Announce Type: new Abstract: Gliomas, among the most common primary brain tumors, vary widely in aggressiveness, prognosis, and histology, making treatment challenging due to complex and time-intensive surgical interventions. This study presents an Attention-Gated Recurrent Residual U-Net (R2U-Net) based Triplanar (2.5D) model for improved brain tumor segmentation. The proposed model enhances feature representation and segmentation accuracy by integrating residual, recurrent, and triplanar architectures while maintaining computational efficiency, potentially aiding in better treatment planning. The proposed method achieves a Dice Similarity Score (DSC) of 0.900 for Whole Tumor (WT) segmentation on the BraTS2021 validation set, demonstrating performance comparable to leading models. Additionally, the triplanar network extracts 64 features per planar model for survival days prediction, which are reduced to 28 using an Artificial Neural Network (ANN). This approach ach
arXiv:2602.15067v1 Announce Type: new Abstract: Gliomas, among the most common primary brain tumors, vary widely in aggressiveness, prognosis, and histology, making treatment challenging due to complex and time-intensive surgical interventions. This study presents an Attention-Gated Recurrent Residual U-Net (R2U-Net) based Triplanar (2.5D) model for improved brain tumor segmentation. The proposed model enhances feature representation and segmentation accuracy by integrating residual, recurrent, and triplanar architectures while maintaining computational efficiency, potentially aiding in better treatment planning. The proposed method achieves a Dice Similarity Score (DSC) of 0.900 for Whole Tumor (WT) segmentation on the BraTS2021 validation set, demonstrating performance comparable to leading models. Additionally, the triplanar network extracts 64 features per planar model for survival days prediction, which are reduced to 28 using an Artificial Neural Network (ANN). This approach achieves an accuracy of 45.71%, a Mean Squared Error (MSE) of 108,318.128, and a Spearman Rank Correlation Coefficient (SRC) of 0.338 on the test dataset.
Executive Summary
This article presents an Attention-Gated Recurrent Residual U-Net (R2U-Net) based Triplanar model for improved brain tumor segmentation. The proposed model integrates residual, recurrent, and triplanar architectures to enhance feature representation and segmentation accuracy while maintaining computational efficiency. The model achieves a high Dice Similarity Score (DSC) of 0.900 for Whole Tumor (WT) segmentation on the BraTS2021 validation set, comparable to leading models. Additionally, the triplanar network extracts features for survival days prediction, achieving an accuracy of 45.71% and a Mean Squared Error (MSE) of 108,318.128 on the test dataset. This study has significant implications for treatment planning and survival prognosis in brain tumor patients.
Key Points
- ▸ The proposed Attention-Gated Recurrent Residual U-Net (R2U-Net) based Triplanar model improves brain tumor segmentation accuracy.
- ▸ The model integrates residual, recurrent, and triplanar architectures for enhanced feature representation and computational efficiency.
- ▸ The triplanar network extracts features for survival days prediction and achieves a moderate accuracy of 45.71%.
Merits
Strength in Segmentation Accuracy
The proposed model achieves a high Dice Similarity Score (DSC) of 0.900 for Whole Tumor (WT) segmentation, comparable to leading models.
Computational Efficiency
The model maintains computational efficiency while integrating residual, recurrent, and triplanar architectures.
Demerits
Moderate Accuracy in Survival Prognosis
The triplanar network achieves a moderate accuracy of 45.71% for survival days prediction, which may not be sufficient for clinical decision-making.
Limited Generalizability
The study's results may not be generalizable to other brain tumor datasets or populations, requiring further validation and testing.
Expert Commentary
The article presents a significant contribution to the field of brain tumor segmentation and survival prognosis. The proposed model's ability to integrate residual, recurrent, and triplanar architectures is a notable advancement, and its computational efficiency is a critical consideration in clinical settings. However, the moderate accuracy in survival prognosis raises questions regarding the model's clinical utility. Further validation and testing are necessary to establish the model's generalizability and effectiveness. Additionally, the study's findings have significant implications for treatment planning and policy decisions, highlighting the need for continued research and development in this area.
Recommendations
- ✓ Further validation and testing of the proposed model on diverse brain tumor datasets and populations are necessary to establish its generalizability and effectiveness.
- ✓ The study's findings should be considered in conjunction with other clinical and radiological factors to inform treatment planning and patient outcomes.